Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

New Guidelines: Interpretation, Application and the Future.

Hershey AD, Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Licking N, Sowell M, Victorio MC, Gersz E, Vrijsen E, Zanitsch H, Yonker M, Mack K, Gelfand AA, Szperka CL, Powers SW.

Headache. 2019 Sep;59(8):1133-1143. doi: 10.1111/head.13629. No abstract available.

PMID:
31529478
2.

Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?

LaHue SC, Gelfand AA, Bove RM.

Neurology. 2019 Sep 6. pii: 10.1212/WNL.0000000000008213. doi: 10.1212/WNL.0000000000008213. [Epub ahead of print] Review.

PMID:
31492717
3.

The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey Study.

Gelfand AA, Buse DC, Cabana MD, Grimes B, Goadsby PJ, Allen IE.

Headache. 2019 Jul;59(7):988-1001. doi: 10.1111/head.13575. Epub 2019 Jun 20.

PMID:
31222745
4.

Improving the Patient Experience With Migraine Camp, a One-Day Group Intervention for Adolescents With Chronic Headache and Their Parents.

Hall AL, Karvounides D, Gelfand AA, Mankin H, Kessel S, Corroo J, Malavolta CP, Pezzuto T, Chadehumbe M, Szperka CL.

Headache. 2019 Sep;59(8):1392-1400. doi: 10.1111/head.13570. Epub 2019 Jun 5.

PMID:
31165479
5.

Preliminary Evidence that Melatonin Is not a Biomarker in Children and Adolescents With Episodic Migraine.

Berger A, Litwin J, Allen IE, Qubty W, Irwin S, Waung M, Gelfand AA.

Headache. 2019 Jul;59(7):1014-1023. doi: 10.1111/head.13547. Epub 2019 May 3.

PMID:
31054199
6.

High School Start Time and Migraine Frequency in High School Students.

Gelfand AA, Pavitt S, Greene K, Szperka CL, Irwin S, Grimes B, Allen IE.

Headache. 2019 Jul;59(7):1024-1031. doi: 10.1111/head.13535. Epub 2019 Apr 24.

PMID:
31016722
7.
8.

Potential Benefits of Migraine-What Is It Good For?

Gelfand AA, Loder E.

JAMA Neurol. 2019 Mar 1;76(3):250-251. doi: 10.1001/jamaneurol.2018.3442. No abstract available.

PMID:
30556821
9.

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Szperka CL, VanderPluym J, Orr SL, Oakley CB, Qubty W, Patniyot I, Lagman-Bartolome AM, Morris C, Gautreaux J, Victorio MC, Hagler S, Narula S, Candee MS, Cleves-Bayon C, Rao R, Fryer RH, Bicknese AR, Yonker M, Hershey AD, Powers SW, Goadsby PJ, Gelfand AA.

Headache. 2018 Nov;58(10):1658-1669. doi: 10.1111/head.13414. Epub 2018 Oct 15. No abstract available.

PMID:
30324723
10.

Alternating Gaussian Process Modulated Renewal Processes for Modeling Threshold Exceedances and Durations.

Schliep EM, Gelfand AE, Holland DM.

Stoch Environ Res Risk Assess. 2018 Feb;32(2):401-417. doi: 10.1007/s00477-017-1417-9.

11.

A retrospective analysis of the development of seizure frequency in patients with seizures during a period of military conflict.

Appel S, Gelfand A, Kotlyar G, Milo R.

Seizure. 2018 Oct;61:119-121. doi: 10.1016/j.seizure.2018.08.003. Epub 2018 Aug 7.

PMID:
30125863
12.

Pediatric and Adolescent Headache.

Gelfand AA.

Continuum (Minneap Minn). 2018 Aug;24(4, Headache):1108-1136. doi: 10.1212/CON.0000000000000638. Review.

PMID:
30074552
13.

Occipital Headaches and Neuroimaging in Children.

Irwin SL, Gelfand AA.

Curr Pain Headache Rep. 2018 Jul 10;22(9):59. doi: 10.1007/s11916-018-0712-6. Review.

PMID:
29987497
14.

Cluster Headache and Calcitonin Gene-Related Peptide-More on Quantum Therapeutics in Headache Medicine.

Gelfand AA, Goadsby PJ.

JAMA Neurol. 2018 Oct 1;75(10):1179-1180. doi: 10.1001/jamaneurol.2018.1428. No abstract available.

PMID:
29987331
15.

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.

Dodick DW, Tepper SJ, Friedman DI, Gelfand AA, Kellerman DJ, Schmidt PC.

Headache. 2018 Jul;58(7):986-992. doi: 10.1111/head.13327. Epub 2018 May 21.

16.

Expanding the phenotype of congenital central hypoventilation syndrome impacts management decisions.

Byers HM, Chen M, Gelfand AS, Ong B, Jendras M, Glass IA.

Am J Med Genet A. 2018 Jun;176(6):1398-1404. doi: 10.1002/ajmg.a.38726. Epub 2018 Apr 25.

17.

Telemedicine in a pediatric headache clinic: A prospective survey.

Qubty W, Patniyot I, Gelfand A.

Neurology. 2018 May 8;90(19):e1702-e1705. doi: 10.1212/WNL.0000000000005482. Epub 2018 Apr 6.

PMID:
29626180
18.

Episodic syndromes of childhood associated with migraine.

Gelfand AA.

Curr Opin Neurol. 2018 Jun;31(3):281-285. doi: 10.1097/WCO.0000000000000558. Review.

PMID:
29601304
19.

Migraine is common in patients with sarcoidosis.

Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL.

Cephalalgia. 2018 Dec;38(14):2079-2082. doi: 10.1177/0333102418768037. Epub 2018 Mar 26.

PMID:
29580067
20.

Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.

Irwin SL, Qubty W, Allen IE, Patniyot I, Goadsby PJ, Gelfand AA.

Headache. 2018 May;58(5):724-731. doi: 10.1111/head.13284. Epub 2018 Mar 12.

PMID:
29528485
21.

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).

Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW.

Cephalalgia. 2018 May;38(6):1038-1048. doi: 10.1177/0333102418762525. Epub 2018 Mar 4.

22.

Bayesian Modeling and Analysis of Geostatistical Data.

Gelfand AE, Banerjee S.

Annu Rev Stat Appl. 2017 Mar;4:245-266. doi: 10.1146/annurev-statistics-060116-054155. Epub 2016 Nov 28.

23.

Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.

Buse DC, Powers SW, Gelfand AA, VanderPluym JH, Fanning KM, Reed ML, Adams AM, Lipton RB.

Headache. 2018 Apr;58(4):512-524. doi: 10.1111/head.13254. Epub 2018 Jan 22.

PMID:
29355924
24.

Experts' opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta.

Özge A, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, Valeriani M, Sergeev A, Barlow K, Uludüz D, Yalın OÖ, Faedda N, Lipton RB, Rapoport A, Guidetti V.

J Headache Pain. 2017 Nov 29;18(1):113. doi: 10.1186/s10194-017-0819-x.

25.

Experts' opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents.

Özge A, Faedda N, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, Valeriani M, Sergeev A, Barlow K, Uludüz D, Yalın OÖ, Lipton RB, Rapoport A, Guidetti V.

J Headache Pain. 2017 Nov 23;18(1):109. doi: 10.1186/s10194-017-0818-y. Review.

26.

Analyses and interpretation of cannabis use among NHANES adults.

Gelfand A, Tangney CC.

Eur J Prev Cardiol. 2018 Jan;25(1):40-41. doi: 10.1177/2047487317736390. Epub 2017 Oct 20. No abstract available.

PMID:
29053022
27.

Accommodating the ecological fallacy in disease mapping in the absence of individual exposures.

Wang F, Wang J, Gelfand A, Li F.

Stat Med. 2017 Dec 30;36(30):4930-4942. doi: 10.1002/sim.7494. Epub 2017 Sep 19.

PMID:
28929501
28.

Occipital headaches and neuroimaging in children.

Bear JJ, Gelfand AA, Goadsby PJ, Bass N.

Neurology. 2017 Aug 1;89(5):469-474. doi: 10.1212/WNL.0000000000004186. Epub 2017 Jun 30.

29.

Pediatric Migraine Prevention-First, Do No Harm.

Gelfand AA, Qubty W, Goadsby PJ.

JAMA Neurol. 2017 Aug 1;74(8):893-894. doi: 10.1001/jamaneurol.2017.1011. Review. No abstract available.

PMID:
28628697
30.

Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment.

Tso AR, Patniyot IR, Gelfand AA, Goadsby PJ.

Neurology. 2017 Jul 18;89(3):279-283. doi: 10.1212/WNL.0000000000004108. Epub 2017 Jun 14.

31.

Melatonin in the Treatment of Primary Headache Disorders.

Gelfand AA.

Headache. 2017 Jun;57(6):848-849. doi: 10.1111/head.13138. No abstract available.

PMID:
28594124
32.

Home-Based Trials in Adolescent Migraine: A Randomized Clinical Trial.

Gelfand AA, Qubty W, Patniyot I, Grimes B, Pletcher MJ, Goadsby PJ, Cummings SR.

JAMA Neurol. 2017 Jun 1;74(6):744-745. doi: 10.1001/jamaneurol.2017.0285. No abstract available.

33.

Recurrent Gastrointestinal Disturbance: Abdominal Migraine and Cyclic Vomiting Syndrome.

Irwin S, Barmherzig R, Gelfand A.

Curr Neurol Neurosci Rep. 2017 Mar;17(3):21. doi: 10.1007/s11910-017-0731-4. Review.

PMID:
28283964
34.

Acupuncture for Migraine Prevention: Still Reaching for Convincing Evidence.

Gelfand AA.

JAMA Intern Med. 2017 Apr 1;177(4):516-517. doi: 10.1001/jamainternmed.2016.9404. No abstract available.

PMID:
28241222
35.

Neck-Tongue syndrome: A systematic review.

Gelfand AA, Johnson H, Lenaerts ME, Litwin JR, De Mesa C, Bogduk N, Goadsby PJ.

Cephalalgia. 2018 Feb;38(2):374-382. doi: 10.1177/0333102416681570. Epub 2017 Jan 18.

PMID:
28100071
36.

Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents.

Qubty W, Gelfand AA.

Curr Pain Headache Rep. 2016 Dec;20(12):69. Review.

PMID:
27896587
37.
38.

On nearest-neighbor Gaussian process models for massive spatial data.

Datta A, Banerjee S, Finley AO, Gelfand AE.

Wiley Interdiscip Rev Comput Stat. 2016 Sep-Oct;8(5):162-171. doi: 10.1002/wics.1383. Epub 2016 Aug 4.

39.

The Role of Melatonin in the Treatment of Primary Headache Disorders.

Gelfand AA, Goadsby PJ.

Headache. 2016 Sep;56(8):1257-66. doi: 10.1111/head.12862. Epub 2016 Jun 17. Review.

40.

The Link Between Infantile Colic and Migraine.

Qubty W, Gelfand AA.

Curr Pain Headache Rep. 2016 May;20(5):31. doi: 10.1007/s11916-016-0558-8. Review.

PMID:
27038970
41.

Infant Colic.

Gelfand AA.

Semin Pediatr Neurol. 2016 Feb;23(1):79-82. doi: 10.1016/j.spen.2015.08.003. Epub 2015 Aug 17. Review.

42.

Review of Prevention for Pediatric and Adolescent Migraine.

Qubty W, Gelfand AA.

Pediatr Neurol Briefs. 2016 Jan;30(1):5. doi: 10.15844/pedneurbriefs-30-1-4.

43.

Predictors of Triptan Response in Pediatric Migraine.

Johnson HF, Goadsby PJ, Gelfand AA.

Pediatr Neurol. 2016 May;58:37-40. doi: 10.1016/j.pediatrneurol.2016.01.022. Epub 2016 Mar 8.

44.

Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.

Eller M, Gelfand AA, Riggins NY, Shiboski S, Schankin C, Goadsby PJ.

Neurology. 2016 Mar 1;86(9):856-9. doi: 10.1212/WNL.0000000000002406. Epub 2016 Feb 3.

45.

Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic Review.

Patniyot IR, Gelfand AA.

Headache. 2016 Jan;56(1):49-70. doi: 10.1111/head.12746. Review.

PMID:
26790849
46.

Hierarchical Nearest-Neighbor Gaussian Process Models for Large Geostatistical Datasets.

Datta A, Banerjee S, Finley AO, Gelfand AE.

J Am Stat Assoc. 2016;111(514):800-812. doi: 10.1080/01621459.2015.1044091. Epub 2016 Aug 18.

47.

Cyclic vomiting syndrome versus inborn errors of metabolism: A review with clinical recommendations.

Gelfand AA, Gallagher RC.

Headache. 2016 Jan;56(1):215-21. doi: 10.1111/head.12749. Epub 2015 Dec 18.

48.

Supplicant of the Spheres #3.

Gelfand A.

J Pain Palliat Care Pharmacother. 2015;29(4):331. doi: 10.3109/15360288.2015.1103353. No abstract available.

PMID:
26654405
49.

A multivariate spatial mixture model for areal data: examining regional differences in standardized test scores.

Neelon B, Gelfand AE, Miranda ML.

J R Stat Soc Ser C Appl Stat. 2014 Nov;63(5):737-761.

50.

Episodic Syndromes That May Be Associated With Migraine: A.K.A. "the Childhood Periodic Syndromes".

Gelfand AA.

Headache. 2015 Nov-Dec;55(10):1358-64. doi: 10.1111/head.12624. Epub 2015 Aug 3. Review.

Supplemental Content

Loading ...
Support Center